🇺🇸 SRPT — Sarepta Therapeutics, Inc.
Salud MantenerPrecio actual
17,57 USD
Máx. histórico
178,74
2144 días
Split 1:6 del 12/07/2012
Caída desde máximo
-90,17%
Rango 52 semanas
14,68 – 24,68
Variación hoy
-7,48%
Cierre anterior
18,99
Rango de hoy
17,44 – 18,92
Volumen hoy
1.859.162
Peor caída histórica
-98,17%
09/02/2000 → 18/12/2008
Recuperado en 3568 días
Volatilidad anualizada ⓘ
95,43%
- Nombre completo
- Sarepta Therapeutics, Inc.
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 835
- PER ⓘ
- —
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 21,64 USD (puede no estar actualizado)
- Primera cotización
- 04/06/1997
- Precio actualizado
- hace 11 horas
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.
| Fecha | Ratio |
|---|---|
| 12/07/2012 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 11/02/2021 | 93,80 | 93,97 | 90,33 | 90,77 | -2,46% | 3,88% | 1.082.100 |
| 10/02/2021 | 93,88 | 95,60 | 91,13 | 93,06 | -0,13% | 4,76% | 1.148.200 |
| 09/02/2021 | 95,79 | 96,68 | 92,82 | 93,18 | -2,20% | 4,03% | 1.069.200 |
| 08/02/2021 | 96,20 | 96,88 | 93,65 | 95,28 | -0,53% | 3,36% | 1.155.600 |
| 05/02/2021 | 96,32 | 96,79 | 94,25 | 95,79 | +0,06% | 2,64% | 908.300 |
| 04/02/2021 | 93,39 | 95,73 | 92,32 | 95,73 | +3,54% | 3,65% | 1.210.900 |
| 03/02/2021 | 90,98 | 93,15 | 90,19 | 92,46 | +2,53% | 3,25% | 1.147.400 |
| 02/02/2021 | 90,87 | 92,80 | 89,93 | 90,18 | +0,21% | 3,16% | 1.297.500 |
| 01/02/2021 | 90,00 | 90,48 | 87,31 | 89,99 | +0,66% | 3,52% | 1.125.400 |
| 29/01/2021 | 89,35 | 92,87 | 87,50 | 89,40 | -0,81% | 6,01% | 1.441.300 |
| 28/01/2021 | 91,00 | 92,40 | 88,62 | 90,13 | -0,40% | 4,15% | 1.913.200 |
| 27/01/2021 | 90,31 | 92,70 | 86,80 | 90,49 | -2,33% | 6,53% | 1.753.200 |
| 26/01/2021 | 95,67 | 96,85 | 92,54 | 92,65 | -3,60% | 4,51% | 1.612.100 |
| 25/01/2021 | 98,94 | 99,84 | 91,53 | 96,11 | -2,17% | 8,40% | 2.383.600 |
| 22/01/2021 | 95,76 | 98,79 | 95,45 | 98,24 | +1,36% | 3,49% | 1.445.700 |
| 21/01/2021 | 99,03 | 99,03 | 94,28 | 96,92 | +0,17% | 4,80% | 1.674.100 |
| 20/01/2021 | 99,53 | 103,34 | 96,37 | 96,76 | -0,04% | 7,00% | 2.923.000 |
| 19/01/2021 | 91,99 | 97,14 | 91,20 | 96,80 | +7,17% | 6,46% | 3.496.900 |
| 15/01/2021 | 89,95 | 92,79 | 89,41 | 90,32 | +0,47% | 3,76% | 3.397.000 |
| 14/01/2021 | 86,64 | 90,75 | 85,60 | 89,90 | +3,07% | 5,94% | 3.998.200 |
| 13/01/2021 | 87,40 | 87,80 | 83,78 | 87,22 | -0,07% | 4,60% | 4.971.600 |
| 12/01/2021 | 89,99 | 94,64 | 86,15 | 87,28 | -2,76% | 9,43% | 6.314.800 |
| 11/01/2021 | 87,20 | 96,21 | 84,16 | 89,76 | +9,08% | 13,82% | 13.516.600 |
| 08/01/2021 | 85,00 | 88,48 | 82,25 | 82,29 | -51,29% | 7,33% | 22.807.600 |
| 07/01/2021 | 168,72 | 174,30 | 166,93 | 168,95 | +1,50% | 4,37% | 4.745.700 |
| 06/01/2021 | 161,67 | 171,84 | 161,12 | 166,45 | +1,34% | 6,63% | 906.600 |
| 05/01/2021 | 165,15 | 167,00 | 162,02 | 164,25 | -0,63% | 3,02% | 1.588.300 |
| 04/01/2021 | 171,00 | 174,49 | 163,83 | 165,29 | -3,05% | 6,23% | 1.073.900 |
| 31/12/2020 | 172,40 | 172,55 | 168,03 | 170,49 | -0,61% | 2,62% | 720.700 |
| 30/12/2020 | 173,06 | 178,50 | 171,05 | 171,54 | -0,16% | 4,30% | 517.000 |